Alaxia SAS
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.alaxia-pharma.eu
Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Dose Finding Study of STR-324
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- Alaxia SAS
- Target Recruit Count
- 118
- Registration Number
- NCT04582786
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Netherlands
Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients
Phase 1
Terminated
- Conditions
- Cystic FibrosisBronchiectasis
- Interventions
- First Posted Date
- 2015-11-06
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Alaxia SAS
- Target Recruit Count
- 92
- Registration Number
- NCT02598999
- Locations
- 🇫🇷
Eurofins Optimed, Grenoble, France
News
No news found